Results 31 to 40 of about 3,980,763 (249)

Rapidly progressive sensory peripheral neuropathy secondary to Coxiella burnetii infection [PDF]

open access: yesRomanian Journal of Neurology, 2018
Q fever is a zoonosis produced by Coxiella burnetii, with potential neurological complications such as aseptic meningitis, myelitis, encephalitis and peripheral neuropathy.
Adriana Octaviana Dulamea   +1 more
doaj   +1 more source

Clinical-MRI correlations in a European trial of interferon beta-1b in secondary progressive MS.

open access: yes, 2001
Background: The recently completed placebo-controlled multicenter randomized trial of interferon beta-1b (Betaferon) in 718 patients with secondary progressive MS shows significant delay of disease progression and reduction of relapse rate.
Beckmann K   +32 more
core   +1 more source

The New Urban: Towards progressive secondary cities [PDF]

open access: yes, 2014
The development landscape in Asia is changing. As more countries reach middle-income levels, new challenges emerge while old ones evolve, all of which demands increasingly innovative perspectives.

core   +1 more source

Early Clinical Predictors of Long-term Disability Progression in Patients with Multiple Sclerosis

open access: yesIndian Journal of Medical Specialities
Background: One of the unmet therapeutic needs in the treatment of multiple sclerosis (MS) is to prevent the accumulation of irreversible disability. Formulating standardized predictors of conversion in the secondary progressive phase of the relapsing ...
Valentina Georgieva Ignatova   +3 more
doaj   +1 more source

Pathogenic Mechanisms Associated With Different Clinical Courses of Multiple Sclerosis

open access: yesFrontiers in Immunology, 2019
In the majority of patients multiple sclerosis starts with a relapsing remitting course (RRMS), which may at later times transform into secondary progressive disease (SPMS).
Hans Lassmann
doaj   +1 more source

Proportion of alemtuzumab-treated patients converting from relapsing-remitting multiple sclerosis to secondary progressive multiple sclerosis over 6 years

open access: yesMultiple Sclerosis Journal - Experimental, Translational and Clinical, 2020
Background Few data exist concerning conversion to secondary progressive MS in patients treated with disease-modifying therapies. Objective Determine the proportion of alemtuzumab-treated patients converting from relapsing-remitting to secondary ...
Dana Horáková   +13 more
doaj   +1 more source

Chemotherapy for Spinal Cord Intramedullary Pediatric Low‐Grade Glioma—A Systematic Literature Review

open access: yesPediatric Blood &Cancer, EarlyView.
ABSTRACT Pediatric intramedullary low‐grade gliomas (PIMLGGs) are rare neoplasms that present unique clinical and management challenges. Although surgery remains the primary tool for tissue diagnosis and decompression, complete gross‐total resection is frequently unfeasible due to the infiltrative nature of these lesions.
Olga M. Sergeenko   +5 more
wiley   +1 more source

The Culture of the Independent Progressive School [PDF]

open access: yes, 2018
Even in this Age of Data, independent progressive schools have shown a remarkable persistence in offering an alternative educational model. As Traditional Public Schools (TPS) become even more committed to a testing model of achievement, there are ...
Dean Kloss
core   +1 more source

Therapeutic Apheresis in Nigeria: A Multi‐Center Summary of Abstracts From the Inaugural Nigerian Society for Apheresis Scientific Meeting

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Therapeutic apheresis (TA) is an established treatment modality for hematologic, neurologic, and immunologic disorders, yet access remains severely limited in sub‐Saharan Africa. Donor apheresis, including platelet apheresis collection from healthy donors, represents an important complementary modality supporting blood product ...
Nosa Bazuaye   +33 more
wiley   +1 more source

Effectiveness of Resistance Intradialytic Exercise Compared to Aerobic Intradialytic Exercise for Patients With Chronic Kidney Disease: A Randomized Controlled Clinical Trial

open access: yesTherapeutic Apheresis and Dialysis, EarlyView.
ABSTRACT Background Patients with chronic kidney disease undergoing hemodialysis commonly experience reduced physical function, fatigue, poor sleep quality, and impaired health‐related quality of life. Intradialytic exercise has been proposed as a non‐pharmacological strategy to improve these outcomes.
Klebson da Silva Almeida   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy